Orthopediatrics (KIDS) Rating Reiterated by BTIG Research
Orthopediatrics (NASDAQ:KIDS)‘s stock had its “buy” rating reaffirmed by stock analysts at BTIG Research in a research report issued to clients and investors on Friday. They presently have a $24.00 target price on the stock. BTIG Research’s price objective indicates a potential upside of 19.70% from the company’s current price.
A number of other equities research analysts also recently commented on the stock. William Blair started coverage on shares of Orthopediatrics in a research report on Monday, November 6th. They issued an “outperform” rating for the company. Piper Jaffray Companies initiated coverage on shares of Orthopediatrics in a research note on Monday, November 6th. They set an “overweight” rating and a $24.00 price target on the stock. Finally, Stifel Nicolaus initiated coverage on shares of Orthopediatrics in a research note on Monday, November 6th. They set a “buy” rating and a $23.00 price target on the stock.
Shares of Orthopediatrics (NASDAQ KIDS) opened at $20.05 on Friday. The company has a debt-to-equity ratio of -0.38, a current ratio of 2.78 and a quick ratio of 1.00. Orthopediatrics has a 1 year low of $17.03 and a 1 year high of $23.00.
In other Orthopediatrics news, Director Harold Ruf purchased 11,500 shares of the company’s stock in a transaction dated Monday, October 16th. The shares were acquired at an average price of $13.00 per share, for a total transaction of $149,500.00. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.
WARNING: This story was originally reported by Watch List News and is owned by of Watch List News. If you are viewing this story on another website, it was stolen and republished in violation of United States & international copyright and trademark law. The legal version of this story can be read at https://www.watchlistnews.com/orthopediatrics-kids-rating-reiterated-by-btig-research/1797281.html.
OrthoPediatrics Corp. is a United States-based medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems.
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with Analyst Ratings Network's FREE daily email newsletter.